Researchers with Michigan State University and Corewell Health are partnering to study the health effects of lead poisoning in the Grand Rapids area where about one in 10 children has elevated lead levels in their blood, according to state data.
Eli Lilly’s CDK4/6 inhibitor Verzenio barely missed the overall survival endpoint in a Phase III clinical trial for advanced breast cancer. In the MONARCH 3
Results from two phase III trials (NRG-GY018 and RUBY01) presented earlier this year at the Society of Gynecologic Oncology (SGO) annual meeting demonstrated that immunotherapy